Linked Data API

Show Search Form

Search Results

1129747
registered interest false more like this
date less than 2019-06-04more like thismore than 2019-06-04
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Diabetes: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to the Freestyle Libre monitoring device for diabetes patients on the NHS. more like this
tabling member constituency York Outer more like this
tabling member printed
Julian Sturdy more like this
uin 259981 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-12more like thismore than 2019-06-12
answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p> </p><p>Clinical commissioning groups (CCGS) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
grouped question UIN 259980 more like this
question first answered
less than 2019-06-12T16:02:36.423Zmore like thismore than 2019-06-12T16:02:36.423Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4079
label Biography information for Julian Sturdy more like this